In CVS-Aetna, A Novel Review For A Major Industry Shakeup

When CVS and Aetna go to court Tuesday to defend their $69 billion tie-up, they'll face a confrontational judge presiding over an unprecedented trial-like review of the merger settlement the companies...

Already a subscriber? Click here to view full article